Inhibitor Therapeutics, Inc. - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - March 31, 2010

Attached files

file filename
10-K - FORM 10-K - Inhibitor Therapeutics, Inc.d10k.htm
EX-32.2 - EXHIBIT 32.2 - Inhibitor Therapeutics, Inc.dex322.htm
EX-31.2 - EXHIBIT 31.2 - Inhibitor Therapeutics, Inc.dex312.htm
EX-32.1 - EXHIBIT 32.1 - Inhibitor Therapeutics, Inc.dex321.htm
EX-31.1 - EXHIBIT 31.1 - Inhibitor Therapeutics, Inc.dex311.htm
EX-13.1 - EXHIBIT 13.1 - Inhibitor Therapeutics, Inc.dex131.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-51074) and S-3 (No. 333-51078) of Commonwealth Biotechnologies, Inc. of our report dated March 29, 2010, relating to the consolidated financial statements, which appear in the Annual Report to Shareholders, which is incorporated by reference in the Form 10-K.

 

LOGO
/s/ Witt Mares, PLC

Richmond, Virginia

March 30, 2010

Inhibitor Therapeutics, Inc. Reports